Dyckhoff, G.; Warta, R.; Herold-Mende, C.; Rudolph, E.; Plinkert, P.K.; Ramroth, H.
Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients. Cancers 2021, 13, 1601.
https://doi.org/10.3390/cancers13071601
AMA Style
Dyckhoff G, Warta R, Herold-Mende C, Rudolph E, Plinkert PK, Ramroth H.
Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients. Cancers. 2021; 13(7):1601.
https://doi.org/10.3390/cancers13071601
Chicago/Turabian Style
Dyckhoff, Gerhard, Rolf Warta, Christel Herold-Mende, Elisabeth Rudolph, Peter K. Plinkert, and Heribert Ramroth.
2021. "Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients" Cancers 13, no. 7: 1601.
https://doi.org/10.3390/cancers13071601
APA Style
Dyckhoff, G., Warta, R., Herold-Mende, C., Rudolph, E., Plinkert, P. K., & Ramroth, H.
(2021). Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients. Cancers, 13(7), 1601.
https://doi.org/10.3390/cancers13071601